PRESS RELEASE published on 07/31/2025 at 09:17, 1 year 3 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à plusieurs conférences investisseurs à venir en septembre et octobre 2025. La société présentera ses avancées dans le domaine de la biotechnologie et des thérapies pour la perte auditive Biotechnologie Conférences Investisseurs Sensorion Perte Auditive Thérapies Auditives
BRIEF published on 07/01/2025 at 07:35, 1 year 4 months ago Sensorion Reports Positive Preliminary Data from Audiogene Phase 1/2 Trial Gene Therapy Sensorion SENS-501 Congenital Deafness Audiogene Trial
BRIEF published on 07/01/2025 at 07:35, 1 year 4 months ago Sensorion publie des données préliminaires positives issues de l'essai de phase 1/2 d'Audiogene Thérapie Génique Sensorion SENS-501 Surdité Congénitale Essai Audiogene
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 4 months ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 4 months ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
BRIEF published on 05/06/2025 at 07:35, 1 year 5 months ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
Published on 10/30/2026 at 23:35, 2 days 9 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 9 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 14 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 17 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/02/2026 at 09:00, 15 minutes ago Original-Research: Gallmetzer HealthCare SpA (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 15 minutes ago Original-Research: bet-at-home.com AG (von NuWays AG): BUY
Published on 11/02/2026 at 09:00, 15 minutes ago Mutares has sold SRT Group and its subsidiaries to Quiver
Published on 11/02/2026 at 09:00, 15 minutes ago hep global increases revenue and EBIT in the first half of 2026
Published on 11/02/2026 at 09:00, 15 minutes ago naoo Play Approaches Launch: Over 130 Series with More Than 7,600 Episodes Licensed
Published on 11/02/2026 at 08:40, 35 minutes ago Octobre 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 10/30/2026 at 23:00, 2 days 10 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 10 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
